Ebselen Completed Phase 2 Trials for Menière's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03325790SPI-1005 for the Treatment of Patients With Meniere's Disease